JAZZ vs MSFT: Which Stock is Better?

Side-by-side comparison of Jazz Pharmaceuticals Plc and Microsoft Corp in 2026

Comparison Updated:

JAZZ

Jazz Pharmaceuticals Plc

$203.42

MSFT

Microsoft Corp

$422.50

Key Metrics Comparison

MetricJAZZMSFTWinner
Market Cap$12.52BN/AJAZZ
P/E RatioN/A26.31MSFT
EPS (TTM)$N/A$16.07MSFT
Revenue Growth0.1%0.2%MSFT
Gross Margin91.7%68.6%JAZZ

Analyze JAZZ

Full quant analysis

Analyze MSFT

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is JAZZ or MSFT a better investment?

Comparing JAZZ and MSFT: Jazz Pharmaceuticals Plc has a market cap of $12.52B while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between JAZZ and MSFT?

JAZZ (Jazz Pharmaceuticals Plc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: JAZZ or MSFT?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: JAZZ or MSFT?

MSFT has higher revenue growth at 0.2% vs 0.1% for JAZZ.

Which company is more profitable: JAZZ or MSFT?

Jazz Pharmaceuticals Plc (JAZZ) has higher gross margins at 91.7% compared to 68.6% for MSFT.

Which is the larger company: JAZZ or MSFT?

Jazz Pharmaceuticals Plc (JAZZ) is larger with a market cap of $12.52B compared to N/A for MSFT.

Should I buy JAZZ or MSFT in 2026?

Both JAZZ and MSFT have investment merit. JAZZ trades at $203.42 while MSFT trades at $422.50. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between JAZZ and MSFT stock?

Key differences: Market Cap ($12.52B vs N/A), P/E Ratio (N/A vs 26.3x), Revenue Growth (0.1% vs 0.2%), Gross Margin (91.7% vs 68.6%).

Popular Stock Comparisons